****Registration for this event is now closed, if you are interested in registering please email laurabacchus@onenucleus.com****

Over the last decade, cell and gene therapies have made remarkable progress, and deal-making in this space is rising rapidly. Join our panel event, hosted by Bristows, to discuss the latest opportunities and challenges involved in M&A, VC and licensing transactions in this area. The session will cover topics such as “what makes these different to deals for small molecules or other types of therapies?” and “what are the top priorities for those looking to invest in, or acquire, cell or gene therapy businesses?” The expert panel will share their valuable insights on M&A trends, lessons learnt from licensing deals, the regulatory landscape that impacts these deals, and key ingredients needed to make them a success.

Panel
Claire Smith, Bristows
Jodie Albutt, Quell Therapeutics
Nuno Alves, Astellas Pharma
Graeme Fielder, Aviadobio
Pedro Correa de Sampaio, Neobe Therapeutics

Agenda
18.00 – Arrival & Networking
18.30 – Panel Discussion
19.30 – Networking
21.00 – Close

Refreshments will be provided during the networking.

Prices:
Members: Free
Non-members: £50 +VAT
Academics: please contact alicia@onenucleus.com